Glucotrack announces reverse stock split

1-for-5 reverse stock split to become effective as of the opening of trading on may 20, 2024 rutherford, nj, may 15, 2024 (globe newswire) -- glucotrack, inc. (nasdaq: gctk) (“glucotrack” or the “company”), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that it will effect a 1-for-5 reverse stock split (the “reverse stock split”) of its issued and outstanding common stock (the “common stock”), effective with the opening of trading on monday, may 20, 2024. glucotrack's common stock will continue to trade on the nasdaq capital market (“nasdaq”) under the symbol “gctk”.
GCTK Ratings Summary
GCTK Quant Ranking